Document Detail

Pulmonary hypertension in chronic liver disease.
MedLine Citation:
PMID:  8665788     Owner:  NLM     Status:  MEDLINE    
Pulmonary hypertension develops in approximately 2% of patients with portal hypertension. Diagnosis is often difficult and requires a high degree of clinical suspicion. Treatment of patients with portal and pulmonary hypertension is limited, and mean survival following diagnosis is approximately 15 months. The effect of liver transplantation on the natural history of disease is discussed.
M S Mandell; B M Groves
Related Documents :
20704168 - Pulmonary arterial hypertension: an update on diagnosis and treatment.
2190918 - 1989 corcoran lecture: adaptive and maladaptive responses of the arterial wall to hyper...
17207488 - Stress-strain behavior of the passive basilar artery in normotension and hypertension.
16315058 - Generalized arterial calcification of infancy: two siblings with prolonged survival.
6154338 - Successful palliation by means of a bovine artery graft in a 4-day-old infant with type...
7996068 - Hemorrhagic gastroesophageal ulceration by pulmonary infection in extrahepatic cholesta...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinics in chest medicine     Volume:  17     ISSN:  0272-5231     ISO Abbreviation:  Clin. Chest Med.     Publication Date:  1996 Mar 
Date Detail:
Created Date:  1996-08-08     Completed Date:  1996-08-08     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7907612     Medline TA:  Clin Chest Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  17-33     Citation Subset:  IM    
Department of Anesthesiology, University of Colorado Health Sciences Center, Denver, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Chronic Disease
Endothelium, Vascular
Hypertension, Portal / complications*,  diagnosis,  surgery
Hypertension, Pulmonary / diagnosis,  drug therapy,  etiology*,  mortality,  physiopathology
Liver Diseases / complications,  physiopathology,  surgery
Liver Transplantation
Lung / blood supply
Survival Rate
Vasodilator Agents / therapeutic use
Reg. No./Substance:
0/Vasodilator Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mediators, cytokines, and growth factors in liver-lung interactions.
Next Document:  Hepatopulmonary syndrome. A pulmonary vascular complication of liver disease.